(Q34030359)

30 July 2017

title

Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen (English)

1 reference

30 July 2017

1 reference

Krahn MD

1

1 reference

30 July 2017

Coombs A

series ordinal

2

1 reference

30 July 2017

Levy IG

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

30 July 2017

number of pages

9

1 reference

Canadian Medical Association Journal

inferred from page(s)

published in

1 reference

30 July 2017

volume

160

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

49-57

1 reference

Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Direct and indirect costs of asthma in Canada, 1990

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Physicians in health care management: 4. Case Mix Groups and Resource Intensity Weights: physicians and hospital funding

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Current and future costs of cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Physicians in health care management: 3. Case Mix Groups and Resource Intensity Weights: an overview for physicians

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

An evaluation of prostate-specific antigen as a screening test for prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

The role of increasing detection in the rising incidence of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Philosophical origins of the economic valuation of life.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

The cost of prostatic cancer in a defined population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Clinical economics. A guide to the economic analysis of clinical practices

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

A clinician's guide to cost-effectiveness analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Economics of screening for carcinoma of the prostate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

Prostate cancer screening: what we know and what we need to know.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1229945

The state of the art of cost-of-illness estimates

29 October 2018

1 reference

12 December 2020

The measurement iterative loop: A framework for the critical appraisal of need, benefits and costs of health interventions

1 reference

12 December 2020

Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy

1 reference

12 December 2020

The economic cost of illness revisited

1 reference

12 December 2020

Prostate cancer: the epidemiologic perspective

1 reference

12 December 2020

Measuring the cost of palliative radiotherapy

1 reference

12 December 2020

Longitudinal screening for prostate cancer with prostate-specific antigen

1 reference

12 December 2020

Economic burden of illness in Canada, 1993. Executive summary and recommendations

1 reference

12 December 2020

Laboratory Survey of Prostate Specific Antigen Testing in Ontario

1 reference

12 December 2020

Identifiers

PMC publication ID

1229945

1 reference

30 July 2017

1 reference